Advertisement
New Zealand markets closed
  • NZX 50

    11,931.32
    -2.99 (-0.03%)
     
  • NZD/USD

    0.5938
    -0.0061 (-1.02%)
     
  • NZD/EUR

    0.5573
    -0.0015 (-0.27%)
     
  • ALL ORDS

    8,050.20
    -23.90 (-0.30%)
     
  • ASX 200

    7,788.10
    -25.50 (-0.33%)
     
  • OIL

    85.45
    +0.43 (+0.51%)
     
  • GOLD

    2,360.20
    -12.50 (-0.53%)
     
  • NASDAQ

    18,003.49
    -304.50 (-1.66%)
     
  • FTSE

    7,995.58
    +71.78 (+0.91%)
     
  • Dow Jones

    37,983.24
    -475.84 (-1.24%)
     
  • DAX

    17,930.32
    -24.16 (-0.13%)
     
  • Hang Seng

    16,721.69
    -373.34 (-2.18%)
     
  • NIKKEI 225

    39,523.55
    +80.92 (+0.21%)
     
  • NZD/JPY

    90.9930
    -0.8880 (-0.97%)
     

Prince Charles opens new AstraZeneca research center

AstraZeneca has supplied two billion doses of its COVID-19 vaccine, developed at Oxford University, and is also looking to bring a preventative antibody cocktail against COVID-19 to market.

Prince Charles, son of Queen Elizabeth and heir to the throne, saw an exhibit on the pandemic and a demonstration of how augmented reality headsets can help with lab work, before hearing about the company's net-zero targets.

Chief Executive Pascal Soriot, who accompanied Charles on a tour through the facility, said the centre would "power the next stage of our company's growth."

AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialized medicines and next-generation therapeutics, including gene-editing and cell therapies.